humanitarian Translated · Українська · 2–5m lag

Звіт про лікування людських ліків (EPAR): Yesintek, ustekinumab, Date of Pritorization: 14/02/2025, modifiate: 5, Status: Authorized

Звіт про лікування людських ліків (EPAR): Oncaspar, peispargase, Date of Pentification: 14/01/2016, revision: 21, Status: Authorized

Reported by EMA What Is New
Read the complete report at EMA What Is New ↗
Verification notice

IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.

INCIDENT FUSION

6 reports · 2 sources

EMA What Is NewЗвіт про лікування людських ліків (EPAR): Yesintek, ustekinumab, Date of Pritorization: 14/02/2025, modifiate: 5, Status: AuthorizedEMA What Is NewЗвіт про лікування людських ліків (EPAR): Yesintek, ustekinumab, Date of Pritorization: 14/02/2025, modifiate: 5, Status: AuthorizedEMA What Is NewHuman medicines European public assessment report (EPAR): Usrenty, ustekinumab, Date of authorisation: 17/09/2025, Revision: 3, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Usrenty, ustekinumab, Date of authorisation: 17/09/2025, Revision: 3, Status: AuthorisedEMA What Is NewЗвіт про лікування людських ліків (EPAR): Abiraterone Mylan, abiraterone acetate, Date of Pentification: 20/08/2021, consument: 8, Status: AuthorizedEMA What Is NewЗвіт про лікування людських ліків (EPAR): Abiraterone Mylan, abiraterone acetate, Date of Pentification: 20/08/2021, consument: 8, Status: Authorized
INCIDENT EVOLUTION

3 recorded states

Signal first indexedP2 · 99% quality · 2 sources

Headline updatedP2 · 99% quality · 2 sources

Source details updatedP2 · 99% quality · 2 sources

Explore this day in the archive →
QUALITY CONTROL

Report this signal

Reports are anonymous and retained privately for editorial review.